Stay updated on Ramucirumab Plus Nivolumab in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Ramucirumab Plus Nivolumab in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ramucirumab Plus Nivolumab in Gastric Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page revision label updated from v3.3.3 to v3.3.4, with no other changes observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-13T19:12:26.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision: v3.3.3 added; HHS Vulnerability Disclosure and Revision: v3.3.2 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T08:48:58.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2; no visible changes to study details or layout.
    Difference
    0.1%
    Check dated 2025-12-01T15:49:33.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1 on the page; core study content and details remain unchanged.
    Difference
    0.1%
    Check dated 2025-11-24T11:34:12.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The government funding/operating status notice was removed from the page. The rest of the study details and page content remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T06:16:01.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The updates appear to be cosmetic adjustments to the page header and layout, with no changes to core study information. There are no changes to eligibility criteria, interventions, or primary/secondary outcomes or dates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T00:48:06.000Z thumbnail image

Stay in the know with updates to Ramucirumab Plus Nivolumab in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ramucirumab Plus Nivolumab in Gastric Cancer Clinical Trial page.